TRICALS for pharma
TRICALS as European trials consortium offers pharma and biotech companies a network of ALS centres with certified research staff trained for all major outcome measurements in ALS.
We have a database with ALS patient cohorts, with information on all major patient characteristics. We have ALS-FRS-R data available of ALS patients who are willing to participate in clinical trials. This enables optimal patient selection for clinical trials.
We can offer logistic support in handling protocols and help with guiding protocols through the IRB. If preferred, TRICALS can also offer clinical research support (CRO services).